Brixton Biosciences
PrivateLast Round
Grant
Oct 24, 2024
Total Funding Raised
$37M
Company Overview
Brixton Biosciences is a biotechnology company developing innovative, drug-free injectable therapies for chronic and acute pain management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
interventional pain managementnerve blockmedical devicecryoneurolysisnon-opioid pain reliefpain management deviceambulatory surgery centerASCFDA breakthrough devicenerve block therapypain blocknerve freezingclinical-stage biotech
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brixton Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Brixton Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 24, 2024 | ||||
| Series B | May 14, 2024 |
Key People
Founding team and executive leadership
Brixton Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Health Investors | Series B |
| NIH RADx | Grant |
| Sparta Group LLC | Series B |
| Pritzker Vlock Family Office | Series B |
| Schooner Capital | Series B |
| Catalyst Health Ventures | Series B |
| Excelestar Ventures | Series B |
Brixton Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Brixton Biosciences's valuation, stock price, and market status.
Firmographic Details
HeadquartersCambridge, Massachusetts
Employee Range27
Year Founded2018
Last FundingOct 24, 2024